Atlantic Bio Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 1.95 M
as on 15-06-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 Cr
as on 15-06-2024
- Revenue 33.02%
(FY 2023)
- Profit 9.28%
(FY 2023)
- Ebitda 4.56%
(FY 2023)
- Net Worth 6.81%
(FY 2023)
- Total Assets 9.24%
(FY 2023)
About Atlantic Bio Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.95 M.
The company currently has active open charges totaling ₹6.00 Cr.
Varun Vazirani and Ravi Vazirani serve as directors at the Company.
- CIN/LLPIN
U24239MH2008PTC182889
- Company No.
182889
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Atlantic Bio Medical Private Limited offer?
Atlantic Bio Medical Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Carboxylate Esters, Nutraceuticals & Dietary Supplements, Mineral Supplement, Surgical & ICU Equipments, Dialysis Machine, Industrial Chemicals & Supplies, Disinfectant Chemicals, Cleaning Chemicals, Medical Instrument Disinfectants.
Who are the key members and board of directors at Atlantic Bio Medical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Vazirani  | Director | 13-Jan-2020 | Current |
| Ravi Vazirani | Additional Director | 01-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Atlantic Bio Medical.
Atlantic Bio Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.02% increase. The company also saw a slight improvement in profitability, with a 9.28% increase in profit. The company's net worth moved up by a moderate rise of 6.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atlantic Bio Medical?
In 2023, Atlantic Bio Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 May 2023 | ₹6.00 Cr | Open |
How Many Employees Work at Atlantic Bio Medical?
Atlantic Bio Medical has a workforce of 16 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atlantic Bio Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atlantic Bio Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
